Manipal Health Enterprises has debuted at Rs 655.00 on the BSE, up by 65.00 points or 11.02% from its issue price of Rs 590.00.
The scrip is currently trading at Rs. 653.70, up by 63.70 points or 10.80% from its issue price.
It has touched a high and low of Rs. 660.00 and Rs. 634.55 respectively. So far 28.08 lakh shares were traded on the counter.
The offering, which was open for subscription July 29, 2026 to August 31, 2026 was subscribed 5.12 times. The issue price was fixed at Rs 590 per share i.e. at upper end of price band of Rs 560-590 apiece.
Manipal Health Enterprises operates a pan India network of multispecialty hospitals delivering a comprehensive range of care services - from outpatient services to complex tertiary and quaternary interventions. It offers clinical services across several specialties, with a focus on tertiary and quaternary care, particularly in cardiac sciences, oncology, neurosciences, gastro sciences, orthopedics, and renal sciences (CONGO R).
| Company Name | CMP |
|---|---|
| Apollo Hospital Ent. | 8980.50 |
| Max Healthcare Inst. | 1073.00 |
| Narayana Hrudayalay. | 1884.00 |
| Aster DM Quality | 870.30 |
| Global Health | 1455.00 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: